These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1681654)
1. The occurrence of antinuclear, anti-SSA/Ro and anti-SSB/La antibodies in patients with polymorphous light eruption. Kiss M; Husz S; Dobozy A Acta Derm Venereol; 1991; 71(4):341-3. PubMed ID: 1681654 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. Faria AC; Barcellos KS; Andrade LE J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063 [TBL] [Abstract][Full Text] [Related]
3. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease. Setty YN; Pittman CB; Mahale AS; Greidinger EL; Hoffman RW J Rheumatol; 2002 Mar; 29(3):487-9. PubMed ID: 11908561 [TBL] [Abstract][Full Text] [Related]
4. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features. Synkowski DR; Reichlin M; Provost TT J Rheumatol; 1982; 9(3):380-5. PubMed ID: 6981704 [TBL] [Abstract][Full Text] [Related]
5. Spectrum and clinical significance of autoantibodies against transfer RNA. Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095 [TBL] [Abstract][Full Text] [Related]
6. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases. Yamagata H; Akizuki M; Tojo T; Homma M Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876 [TBL] [Abstract][Full Text] [Related]
8. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467 [TBL] [Abstract][Full Text] [Related]
10. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. Meyer O Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426 [TBL] [Abstract][Full Text] [Related]
11. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study]. Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670 [TBL] [Abstract][Full Text] [Related]
12. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome. Maran R; Dueymes M; Pennec YL; Casburn-Budd R; Shoenfeld Y; Youinou P J Autoimmun; 1993 Jun; 6(3):379-87. PubMed ID: 8397718 [TBL] [Abstract][Full Text] [Related]
13. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984 [TBL] [Abstract][Full Text] [Related]
14. [Anti- SSA/Ro and Anti-SSB/ La Antibodies in Patients with Yusho]. Tsuji H Fukuoka Igaku Zasshi; 2015 May; 106(5):119-23. PubMed ID: 26226671 [TBL] [Abstract][Full Text] [Related]
16. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity. Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967 [TBL] [Abstract][Full Text] [Related]
17. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885 [TBL] [Abstract][Full Text] [Related]
19. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229 [TBL] [Abstract][Full Text] [Related]
20. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]